Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Aleesha Shaik"'
Autor:
Aleesha, Shaik, Qinzhong, Chen, Phyu, Mar, HyoungSup, Kim, Priscilla, Mejia, Hannah, Pacheco, Sascha N, Goonewardena, Daniel J, Cho, Robert S, Rosenson
Publikováno v:
Clinical Hemorheology and Microcirculation. 82:149-155
BACKGROUND: Elevated estimated blood viscosity (EBV), derived from hematocrit and globulins, is associated with thrombotic complications, organ failure, and higher mortality in COVID-19 patients. Although informative, EBV does not account for cellula
Autor:
Daein Choi, Ori Waksman, Aleesha Shaik, Phyu Mar, Qinzhong Chen, Daniel J. Cho, HyoungSup Kim, Robin L. Smith, Sascha N. Goonewardena, Robert S. Rosenson
Publikováno v:
Journal of the American College of Cardiology. 80:316-328
Coronavirus disease-2019 (COVID-19) is characterized by a dysfunctional immune response and abnormal blood rheology that contribute to endothelial dysfunction and thrombotic complications. Whole blood viscosity (WBV) is a clinically validated measure
Publikováno v:
Journal of the American College of Cardiology. 78:1817-1830
Emerging evidence suggests that elevated concentrations of triglyceride-rich lipoprotein remnants (TRLs) derived from hepatic and intestinal sources contribute to the risk of atherosclerotic cardiovascular events. Natural selection studies support a
Autor:
Aleesha, Shaik, Mikhail, Kosiborod, James A, de Lemos, Qi, Gao, Katherine E, Mues, Shushama, Alam, Deepak L, Bhatt, Christopher P, Cannon, Christie M, Ballantyne, Robert S, Rosenson
Publikováno v:
Clinical cardiologyREFERENCES.
Chronic kidney disease (CKD) is a known risk factor of atherosclerotic cardiovascular disease (ASCVD). Per the 2018 American Heart Association/American College of Cardiology cholesterol guidelines, high-risk ASCVD patients with CKD and low-density li
Autor:
Robert S. Rosenson, Aleesha Shaik
Publikováno v:
Cardiovascular Drugs and Therapy. 35:677-690
Objective: Despite aggressive reduction of low-density lipoprotein cholesterol (LDL-C), there is a residual risk of cardiovascular disease (CVD). Hypertriglyceridemia is known to be associated with increased CVD risk, independently of LDL-C. Triglyce
Publikováno v:
Journal of the Society for Cardiovascular Angiography & Interventions. :101039
Autor:
Aleesha, Shaik, Robert S, Rosenson
Publikováno v:
Cardiovascular drugs and therapy. 35(3)
Despite aggressive reduction of low-density lipoprotein cholesterol (LDL-C), there is a residual risk of cardiovascular disease (CVD). Hypertriglyceridemia is known to be associated with increased CVD risk, independently of LDL-C. Triglycerides are o
Autor:
Daein Choi, Ori Waksman, Aleesha Shaik, Phyu Mar, Qinzhong Chen, Daniel Cho, Robin Smith, Sascha Goonewardena, Robert S. Rosenson
Publikováno v:
Journal of the American College of Cardiology. 79:2110
Autor:
Daein Choi, Ori Waksman, Aleesha Shaik, Phyu Mar, Qinzhong Chen, Daniel Cho, Robin Smith, Sascha Goonewardena, Robert S. Rosenson
Publikováno v:
Journal of the American College of Cardiology. 79:1847
Autor:
Aleesha Shaik, Christopher Cannon, Yuyin Liu, Katherine Mues, Shushama Alam, James de Lemos, Deepak Bhatt, Christie Ballantyne, Mikhail Kosiborod, Robert Rosenson
Publikováno v:
Journal of Clinical Lipidology. 15:e1